AU1291601A - Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr - Google Patents

Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr

Info

Publication number
AU1291601A
AU1291601A AU12916/01A AU1291601A AU1291601A AU 1291601 A AU1291601 A AU 1291601A AU 12916/01 A AU12916/01 A AU 12916/01A AU 1291601 A AU1291601 A AU 1291601A AU 1291601 A AU1291601 A AU 1291601A
Authority
AU
Australia
Prior art keywords
prognosis
pcr
diagnosis
cancer
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12916/01A
Other languages
English (en)
Inventor
Eleftherios Georgakopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIMEART Ltd
Original Assignee
LIMEART Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIMEART Ltd filed Critical LIMEART Ltd
Publication of AU1291601A publication Critical patent/AU1291601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
AU12916/01A 1999-11-12 2000-11-13 Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr Abandoned AU1291601A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GR990100391 1999-11-12
GR99100391 1999-11-12
GR2000100159 2000-08-05
GR20000100159 2000-08-05
PCT/GR2000/000034 WO2001034837A1 (fr) 1999-11-12 2000-11-13 Diagnostic et pronostic de cancer par detection de l'antigene tumoral 17-1a par rt-pcr

Publications (1)

Publication Number Publication Date
AU1291601A true AU1291601A (en) 2001-06-06

Family

ID=26316690

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12916/01A Abandoned AU1291601A (en) 1999-11-12 2000-11-13 Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr

Country Status (2)

Country Link
AU (1) AU1291601A (fr)
WO (1) WO2001034837A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004303B (el) * 2002-11-05 2003-07-30 Ελευθεριος Γεωργακοπουλος ΝΕΑ ΜΕΘΟΔΟΣ ΑΝΙΧΝΕΥΣΗΣ ΤΟΥ ΚΑΡΚΙΝΙΚΟΥ ΜΕΜΒΡΑΝΙΚΟΥ ΑΝΤΙΓΟΝΟΥ Ep-Cam ΚΑΙ ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΚΥΚΛΟΦΟΡΟΥΝΤΩΝ ΜΙΚΡΟΜΕΤΑΣΤΑΤΙΚΩΝ ΚΑΡΚΙΝΙΚΩΝ ΚΥΤΤΑΡΩΝ ΣΤΟ ΠΕΡΙΦΕΡΙΚΟ ΑΙΜΑ ΑΣΘΕΝΩΝ (ΚΑΙ ΣΕ ΙΣΤΟΥΣ) ΜΕ ΚΑΡΚΙΝΟ ΕΠΙΘΗΛΙΑΚΗΣ ΠΡΟΕΛΕΥΣΗΣ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
AU662906B2 (en) * 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
DE19825082C1 (de) * 1998-06-05 2000-02-24 Gabriele Jaques Nachweisverfahren für epitheliale Tumorzellen mittels Reverse-Transkriptase-Polymerase-Kettenreaktion (RT-PCR)

Also Published As

Publication number Publication date
WO2001034837A1 (fr) 2001-05-17

Similar Documents

Publication Publication Date Title
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
ZA99693B (en) Compounds for therapy and diagnosis of lung cancer and methods for their use.
AU4560499A (en) Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1144632A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
EP1175616A4 (fr) Procedes pour le diagnostic et le traitement de tumeurs metastatiques de la prostate
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2608201A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
PL350890A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003218208A1 (en) Methods for diagnosis and prognosis of cancer
AU1744600A (en) Detection of t cell stimulating tumor antigens
IL147486A0 (en) Methods and reagents for determining the prognosis of cancer patients by measuring bag proteins
AU1291601A (en) Diagnosis and prognosis of cancer through detection of the tumor antigen 17-1a by rt-pcr
AUPQ037799A0 (en) Methods for diagnosing and/or predicting the risk of gastric cancer
AU3326000A (en) Means of early examination of malignant tumor
AU5140400A (en) Assay for the detection of paclitaxel resistant cells in human tumors
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 36, PAGE(S) 7808-7811 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 44276/00, 61751/00, 76984/00, 10413/01, 11280/01, 11545/01, 11657/01, 11680/01, 11717/01, 12665/01, 12881/01, 12892/01, 12898/01, 12911/01, 12916/01, 12958/01, 13149/01, 13715/01, 13788/01, 13928/01, 14014/01, 14030/01, 14043/01, 15162/01, 15204/01, 15284/01, 15430/01, 17116/01, 17119/01, 17128/01, 18572/01, 18837/01, 18840/01, 18842/01, 18852/01, 18854/01, 19018/01, 19973/01, 19988/01, 20137/01, 20141/01, 20143/01, 21499/01, 21567/01, 22362/01, 22363/01, 24211/01, 24817/01 AND 26677/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase